ArticleArteriosclerosis, thrombosis, and vascular biology2026

Empagliflozin Improves Angina and Endothelial Dysfunction Indices in Angina and No Obstructive Coronary Arteries (ANOCA).

Danielle N Tapp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.